Figure 1.
Summary of how changes in plasma cholesterol level and in cellular cholesterol content affect macrophage polarization and kinetics in atherosclerotic plaque progression and regression. Left panel: An increase in non-HDL cholesterol (mainly VLDL cholesterol and LDL cholesterol) in mouse models has been linked to an increase in monocyte recruitment into atherosclerotic plaques, with their subsequent polarization to M1 macrophages, which are retained. This ultimately leads to atherosclerotic plaque progression, as evident by plaque enlargement. The failure to clear dead macrophages by efferocytosis results in the appearance of the necrotic core. Right panel: An opposite effect has been demonstrated in atherosclerosis regression models, where a reduction in non-HDL-C or a selective increase in HDL-C (representing an increase in functional HDL particles) induces a decrease in plaque size and macrophage content (from decreased monocyte recruitment and macrophage retention), as well as enrichment in the expression of markers of the M2 state. Improved efferocytosis is also expected under these conditions, with shrinkage of the necrotic core. There is an increase in collagen content, likely from decreased MMP production by the macrophages. It is also likely that in a regression environment there are decreases in the secretion of inflammatory cytokines and chemokines by the macrophages as a result of the polarization of macrophages toward a M2-like state. The different mechanisms by which cholesterol can drive macrophage activation and polarization are divided into those direct – how cholesterol affects macrophages, and indirect – how cholesterol affects other cell types, for example by the secretion of pro-inflammatory cytokines from T cells.